nodes	percent_of_prediction	percent_of_DWPC	metapath
Zuclopenthixol—Mental disorder—Prednisone—rheumatoid arthritis	0.000599	0.000776	CcSEcCtD
Zuclopenthixol—Nausea—Azathioprine—rheumatoid arthritis	0.000598	0.000776	CcSEcCtD
Zuclopenthixol—Tachycardia—Methylprednisolone—rheumatoid arthritis	0.000598	0.000775	CcSEcCtD
Zuclopenthixol—Headache—Leflunomide—rheumatoid arthritis	0.000596	0.000772	CcSEcCtD
Zuclopenthixol—Skin disorder—Methylprednisolone—rheumatoid arthritis	0.000595	0.000772	CcSEcCtD
Zuclopenthixol—Erythema—Prednisone—rheumatoid arthritis	0.000595	0.000771	CcSEcCtD
Zuclopenthixol—Malnutrition—Prednisone—rheumatoid arthritis	0.000595	0.000771	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Hydrocortisone—rheumatoid arthritis	0.000594	0.00077	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Triamcinolone—rheumatoid arthritis	0.000594	0.00077	CcSEcCtD
Zuclopenthixol—Agranulocytosis—Methotrexate—rheumatoid arthritis	0.000594	0.000769	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Methylprednisolone—rheumatoid arthritis	0.000593	0.000768	CcSEcCtD
Zuclopenthixol—Convulsion—Betamethasone—rheumatoid arthritis	0.000592	0.000767	CcSEcCtD
Zuclopenthixol—Convulsion—Dexamethasone—rheumatoid arthritis	0.000592	0.000767	CcSEcCtD
Zuclopenthixol—Insomnia—Hydrocortisone—rheumatoid arthritis	0.00059	0.000765	CcSEcCtD
Zuclopenthixol—Hypertension—Dexamethasone—rheumatoid arthritis	0.00059	0.000764	CcSEcCtD
Zuclopenthixol—Hypertension—Betamethasone—rheumatoid arthritis	0.00059	0.000764	CcSEcCtD
Zuclopenthixol—Paraesthesia—Hydrocortisone—rheumatoid arthritis	0.000586	0.000759	CcSEcCtD
Zuclopenthixol—Myalgia—Dexamethasone—rheumatoid arthritis	0.000582	0.000754	CcSEcCtD
Zuclopenthixol—Myalgia—Betamethasone—rheumatoid arthritis	0.000582	0.000754	CcSEcCtD
Zuclopenthixol—Abdominal pain—Cyclosporine—rheumatoid arthritis	0.00058	0.000752	CcSEcCtD
Zuclopenthixol—Body temperature increased—Cyclosporine—rheumatoid arthritis	0.00058	0.000752	CcSEcCtD
Zuclopenthixol—Anxiety—Betamethasone—rheumatoid arthritis	0.00058	0.000751	CcSEcCtD
Zuclopenthixol—Anxiety—Dexamethasone—rheumatoid arthritis	0.00058	0.000751	CcSEcCtD
Zuclopenthixol—Discomfort—Betamethasone—rheumatoid arthritis	0.000575	0.000745	CcSEcCtD
Zuclopenthixol—Discomfort—Dexamethasone—rheumatoid arthritis	0.000575	0.000745	CcSEcCtD
Zuclopenthixol—Dyspepsia—Hydrocortisone—rheumatoid arthritis	0.000574	0.000744	CcSEcCtD
Zuclopenthixol—Hypotension—Methylprednisolone—rheumatoid arthritis	0.000573	0.000742	CcSEcCtD
Zuclopenthixol—Pain—Prednisolone—rheumatoid arthritis	0.000571	0.00074	CcSEcCtD
Zuclopenthixol—Decreased appetite—Hydrocortisone—rheumatoid arthritis	0.000567	0.000735	CcSEcCtD
Zuclopenthixol—Nausea—Leflunomide—rheumatoid arthritis	0.000565	0.000732	CcSEcCtD
Zuclopenthixol—Urinary tract disorder—Methotrexate—rheumatoid arthritis	0.000564	0.000731	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	0.000563	0.00073	CcSEcCtD
Zuclopenthixol—Fatigue—Hydrocortisone—rheumatoid arthritis	0.000563	0.000729	CcSEcCtD
Zuclopenthixol—Vision blurred—Prednisone—rheumatoid arthritis	0.000561	0.000727	CcSEcCtD
Zuclopenthixol—Urethral disorder—Methotrexate—rheumatoid arthritis	0.00056	0.000726	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Triamcinolone—rheumatoid arthritis	0.00056	0.000725	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Methylprednisolone—rheumatoid arthritis	0.000559	0.000724	CcSEcCtD
Zuclopenthixol—Pain—Hydrocortisone—rheumatoid arthritis	0.000558	0.000723	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Betamethasone—rheumatoid arthritis	0.000557	0.000723	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Dexamethasone—rheumatoid arthritis	0.000557	0.000723	CcSEcCtD
Zuclopenthixol—Insomnia—Triamcinolone—rheumatoid arthritis	0.000556	0.00072	CcSEcCtD
Zuclopenthixol—Insomnia—Methylprednisolone—rheumatoid arthritis	0.000554	0.000719	CcSEcCtD
Zuclopenthixol—Ill-defined disorder—Prednisone—rheumatoid arthritis	0.000552	0.000715	CcSEcCtD
Zuclopenthixol—Paraesthesia—Triamcinolone—rheumatoid arthritis	0.000552	0.000715	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Prednisolone—rheumatoid arthritis	0.000551	0.000714	CcSEcCtD
Zuclopenthixol—Paraesthesia—Methylprednisolone—rheumatoid arthritis	0.00055	0.000713	CcSEcCtD
Zuclopenthixol—Visual impairment—Methotrexate—rheumatoid arthritis	0.00055	0.000713	CcSEcCtD
Zuclopenthixol—Shock—Betamethasone—rheumatoid arthritis	0.000548	0.000711	CcSEcCtD
Zuclopenthixol—Shock—Dexamethasone—rheumatoid arthritis	0.000548	0.000711	CcSEcCtD
Zuclopenthixol—Dyspnoea—Triamcinolone—rheumatoid arthritis	0.000548	0.00071	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Dexamethasone—rheumatoid arthritis	0.000547	0.000709	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Betamethasone—rheumatoid arthritis	0.000547	0.000709	CcSEcCtD
Zuclopenthixol—Agitation—Prednisone—rheumatoid arthritis	0.000547	0.000709	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Betamethasone—rheumatoid arthritis	0.000546	0.000707	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Dexamethasone—rheumatoid arthritis	0.000546	0.000707	CcSEcCtD
Zuclopenthixol—Tachycardia—Dexamethasone—rheumatoid arthritis	0.000544	0.000705	CcSEcCtD
Zuclopenthixol—Tachycardia—Betamethasone—rheumatoid arthritis	0.000544	0.000705	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Cyclosporine—rheumatoid arthritis	0.000541	0.000701	CcSEcCtD
Zuclopenthixol—Dyspepsia—Triamcinolone—rheumatoid arthritis	0.000541	0.000701	CcSEcCtD
Zuclopenthixol—Dyspepsia—Methylprednisolone—rheumatoid arthritis	0.00054	0.000699	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Dexamethasone—rheumatoid arthritis	0.000539	0.000698	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Betamethasone—rheumatoid arthritis	0.000539	0.000698	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Hydrocortisone—rheumatoid arthritis	0.000538	0.000697	CcSEcCtD
Zuclopenthixol—Malaise—Prednisone—rheumatoid arthritis	0.000536	0.000695	CcSEcCtD
Zuclopenthixol—Vertigo—Prednisone—rheumatoid arthritis	0.000534	0.000693	CcSEcCtD
Zuclopenthixol—Eye disorder—Methotrexate—rheumatoid arthritis	0.000534	0.000692	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Hydrocortisone—rheumatoid arthritis	0.000534	0.000692	CcSEcCtD
Zuclopenthixol—Syncope—Prednisone—rheumatoid arthritis	0.000533	0.000691	CcSEcCtD
Zuclopenthixol—Tinnitus—Methotrexate—rheumatoid arthritis	0.000532	0.00069	CcSEcCtD
Zuclopenthixol—Anorexia—Betamethasone—rheumatoid arthritis	0.000531	0.000689	CcSEcCtD
Zuclopenthixol—Anorexia—Dexamethasone—rheumatoid arthritis	0.000531	0.000689	CcSEcCtD
Zuclopenthixol—Cardiac disorder—Methotrexate—rheumatoid arthritis	0.00053	0.000687	CcSEcCtD
Zuclopenthixol—Fatigue—Triamcinolone—rheumatoid arthritis	0.00053	0.000687	CcSEcCtD
Zuclopenthixol—Fatigue—Methylprednisolone—rheumatoid arthritis	0.000529	0.000685	CcSEcCtD
Zuclopenthixol—Asthenia—Cyclosporine—rheumatoid arthritis	0.000527	0.000683	CcSEcCtD
Zuclopenthixol—Pain—Triamcinolone—rheumatoid arthritis	0.000525	0.000681	CcSEcCtD
Zuclopenthixol—Loss of consciousness—Prednisone—rheumatoid arthritis	0.000523	0.000678	CcSEcCtD
Zuclopenthixol—Hypotension—Dexamethasone—rheumatoid arthritis	0.000521	0.000675	CcSEcCtD
Zuclopenthixol—Hypotension—Betamethasone—rheumatoid arthritis	0.000521	0.000675	CcSEcCtD
Zuclopenthixol—Pruritus—Cyclosporine—rheumatoid arthritis	0.000519	0.000673	CcSEcCtD
Zuclopenthixol—Angiopathy—Methotrexate—rheumatoid arthritis	0.000518	0.000672	CcSEcCtD
Zuclopenthixol—Immune system disorder—Methotrexate—rheumatoid arthritis	0.000516	0.000669	CcSEcCtD
Zuclopenthixol—Abdominal pain—Hydrocortisone—rheumatoid arthritis	0.000516	0.000669	CcSEcCtD
Zuclopenthixol—Body temperature increased—Hydrocortisone—rheumatoid arthritis	0.000516	0.000669	CcSEcCtD
Zuclopenthixol—Convulsion—Prednisone—rheumatoid arthritis	0.000515	0.000668	CcSEcCtD
Zuclopenthixol—Hypertension—Prednisone—rheumatoid arthritis	0.000514	0.000666	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Dexamethasone—rheumatoid arthritis	0.000508	0.000658	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Betamethasone—rheumatoid arthritis	0.000508	0.000658	CcSEcCtD
Zuclopenthixol—Myalgia—Prednisone—rheumatoid arthritis	0.000506	0.000656	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Triamcinolone—rheumatoid arthritis	0.000506	0.000656	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Methylprednisolone—rheumatoid arthritis	0.000505	0.000655	CcSEcCtD
Zuclopenthixol—Anxiety—Prednisone—rheumatoid arthritis	0.000505	0.000654	CcSEcCtD
Zuclopenthixol—Insomnia—Betamethasone—rheumatoid arthritis	0.000504	0.000653	CcSEcCtD
Zuclopenthixol—Insomnia—Dexamethasone—rheumatoid arthritis	0.000504	0.000653	CcSEcCtD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Prednisone—rheumatoid arthritis	0.000503	0.000652	CcSEcCtD
Zuclopenthixol—Diarrhoea—Cyclosporine—rheumatoid arthritis	0.000502	0.000651	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Methylprednisolone—rheumatoid arthritis	0.000501	0.00065	CcSEcCtD
Zuclopenthixol—Paraesthesia—Dexamethasone—rheumatoid arthritis	0.000501	0.000649	CcSEcCtD
Zuclopenthixol—Paraesthesia—Betamethasone—rheumatoid arthritis	0.000501	0.000649	CcSEcCtD
Zuclopenthixol—Discomfort—Prednisone—rheumatoid arthritis	0.0005	0.000649	CcSEcCtD
Zuclopenthixol—Mental disorder—Methotrexate—rheumatoid arthritis	0.0005	0.000648	CcSEcCtD
Zuclopenthixol—Erythema—Methotrexate—rheumatoid arthritis	0.000497	0.000644	CcSEcCtD
Zuclopenthixol—Malnutrition—Methotrexate—rheumatoid arthritis	0.000497	0.000644	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Prednisolone—rheumatoid arthritis	0.000492	0.000638	CcSEcCtD
Zuclopenthixol—Dyspepsia—Betamethasone—rheumatoid arthritis	0.000491	0.000636	CcSEcCtD
Zuclopenthixol—Dyspepsia—Dexamethasone—rheumatoid arthritis	0.000491	0.000636	CcSEcCtD
Zuclopenthixol—Body temperature increased—Triamcinolone—rheumatoid arthritis	0.000486	0.000629	CcSEcCtD
Zuclopenthixol—Dizziness—Cyclosporine—rheumatoid arthritis	0.000486	0.000629	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Prednisone—rheumatoid arthritis	0.000485	0.000629	CcSEcCtD
Zuclopenthixol—Abdominal pain—Methylprednisolone—rheumatoid arthritis	0.000485	0.000628	CcSEcCtD
Zuclopenthixol—Decreased appetite—Dexamethasone—rheumatoid arthritis	0.000485	0.000628	CcSEcCtD
Zuclopenthixol—Decreased appetite—Betamethasone—rheumatoid arthritis	0.000485	0.000628	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	0.000481	0.000624	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	0.000481	0.000624	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Hydrocortisone—rheumatoid arthritis	0.000481	0.000623	CcSEcCtD
Zuclopenthixol—Fatigue—Dexamethasone—rheumatoid arthritis	0.000481	0.000623	CcSEcCtD
Zuclopenthixol—Fatigue—Betamethasone—rheumatoid arthritis	0.000481	0.000623	CcSEcCtD
Zuclopenthixol—Shock—Prednisone—rheumatoid arthritis	0.000478	0.000619	CcSEcCtD
Zuclopenthixol—Pain—Betamethasone—rheumatoid arthritis	0.000477	0.000618	CcSEcCtD
Zuclopenthixol—Pain—Dexamethasone—rheumatoid arthritis	0.000477	0.000618	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Prednisone—rheumatoid arthritis	0.000476	0.000617	CcSEcCtD
Zuclopenthixol—Tachycardia—Prednisone—rheumatoid arthritis	0.000474	0.000614	CcSEcCtD
Zuclopenthixol—Skin disorder—Prednisone—rheumatoid arthritis	0.000472	0.000611	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Prednisone—rheumatoid arthritis	0.000469	0.000608	CcSEcCtD
Zuclopenthixol—Vision blurred—Methotrexate—rheumatoid arthritis	0.000469	0.000607	CcSEcCtD
Zuclopenthixol—Asthenia—Hydrocortisone—rheumatoid arthritis	0.000468	0.000607	CcSEcCtD
Zuclopenthixol—Vomiting—Cyclosporine—rheumatoid arthritis	0.000467	0.000605	CcSEcCtD
Zuclopenthixol—Rash—Cyclosporine—rheumatoid arthritis	0.000463	0.0006	CcSEcCtD
Zuclopenthixol—Anorexia—Prednisone—rheumatoid arthritis	0.000463	0.0006	CcSEcCtD
Zuclopenthixol—Dermatitis—Cyclosporine—rheumatoid arthritis	0.000463	0.000599	CcSEcCtD
Zuclopenthixol—Pruritus—Hydrocortisone—rheumatoid arthritis	0.000462	0.000598	CcSEcCtD
Zuclopenthixol—Ill-defined disorder—Methotrexate—rheumatoid arthritis	0.000461	0.000598	CcSEcCtD
Zuclopenthixol—Headache—Cyclosporine—rheumatoid arthritis	0.00046	0.000596	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Dexamethasone—rheumatoid arthritis	0.000459	0.000595	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Betamethasone—rheumatoid arthritis	0.000459	0.000595	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Dexamethasone—rheumatoid arthritis	0.000456	0.000591	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Betamethasone—rheumatoid arthritis	0.000456	0.000591	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Triamcinolone—rheumatoid arthritis	0.000453	0.000587	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Methylprednisolone—rheumatoid arthritis	0.000452	0.000585	CcSEcCtD
Zuclopenthixol—Malaise—Methotrexate—rheumatoid arthritis	0.000448	0.000581	CcSEcCtD
Zuclopenthixol—Vertigo—Methotrexate—rheumatoid arthritis	0.000447	0.000579	CcSEcCtD
Zuclopenthixol—Diarrhoea—Hydrocortisone—rheumatoid arthritis	0.000446	0.000579	CcSEcCtD
Zuclopenthixol—Leukopenia—Methotrexate—rheumatoid arthritis	0.000445	0.000577	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Prednisone—rheumatoid arthritis	0.000442	0.000573	CcSEcCtD
Zuclopenthixol—Dizziness—Prednisolone—rheumatoid arthritis	0.000442	0.000573	CcSEcCtD
Zuclopenthixol—Asthenia—Triamcinolone—rheumatoid arthritis	0.000441	0.000571	CcSEcCtD
Zuclopenthixol—Abdominal pain—Betamethasone—rheumatoid arthritis	0.000441	0.000571	CcSEcCtD
Zuclopenthixol—Abdominal pain—Dexamethasone—rheumatoid arthritis	0.000441	0.000571	CcSEcCtD
Zuclopenthixol—Body temperature increased—Dexamethasone—rheumatoid arthritis	0.000441	0.000571	CcSEcCtD
Zuclopenthixol—Body temperature increased—Betamethasone—rheumatoid arthritis	0.000441	0.000571	CcSEcCtD
Zuclopenthixol—Asthenia—Methylprednisolone—rheumatoid arthritis	0.00044	0.00057	CcSEcCtD
Zuclopenthixol—Insomnia—Prednisone—rheumatoid arthritis	0.000439	0.000569	CcSEcCtD
Zuclopenthixol—Nausea—Cyclosporine—rheumatoid arthritis	0.000436	0.000565	CcSEcCtD
Zuclopenthixol—Paraesthesia—Prednisone—rheumatoid arthritis	0.000436	0.000565	CcSEcCtD
Zuclopenthixol—Pruritus—Triamcinolone—rheumatoid arthritis	0.000435	0.000563	CcSEcCtD
Zuclopenthixol—Pruritus—Methylprednisolone—rheumatoid arthritis	0.000434	0.000562	CcSEcCtD
Zuclopenthixol—Dizziness—Hydrocortisone—rheumatoid arthritis	0.000431	0.000559	CcSEcCtD
Zuclopenthixol—Convulsion—Methotrexate—rheumatoid arthritis	0.000431	0.000558	CcSEcCtD
Zuclopenthixol—Dyspepsia—Prednisone—rheumatoid arthritis	0.000427	0.000554	CcSEcCtD
Zuclopenthixol—Myalgia—Methotrexate—rheumatoid arthritis	0.000423	0.000549	CcSEcCtD
Zuclopenthixol—Decreased appetite—Prednisone—rheumatoid arthritis	0.000422	0.000547	CcSEcCtD
Zuclopenthixol—Rash—Prednisolone—rheumatoid arthritis	0.000421	0.000546	CcSEcCtD
Zuclopenthixol—Dermatitis—Prednisolone—rheumatoid arthritis	0.000421	0.000545	CcSEcCtD
Zuclopenthixol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—rheumatoid arthritis	0.00042	0.000545	CcSEcCtD
Zuclopenthixol—Diarrhoea—Methylprednisolone—rheumatoid arthritis	0.000419	0.000544	CcSEcCtD
Zuclopenthixol—Fatigue—Prednisone—rheumatoid arthritis	0.000419	0.000542	CcSEcCtD
Zuclopenthixol—Headache—Prednisolone—rheumatoid arthritis	0.000419	0.000542	CcSEcCtD
Zuclopenthixol—Discomfort—Methotrexate—rheumatoid arthritis	0.000418	0.000542	CcSEcCtD
Zuclopenthixol—Constipation—Prednisone—rheumatoid arthritis	0.000415	0.000538	CcSEcCtD
Zuclopenthixol—Vomiting—Hydrocortisone—rheumatoid arthritis	0.000415	0.000538	CcSEcCtD
Zuclopenthixol—Rash—Hydrocortisone—rheumatoid arthritis	0.000411	0.000533	CcSEcCtD
Zuclopenthixol—Dermatitis—Hydrocortisone—rheumatoid arthritis	0.000411	0.000533	CcSEcCtD
Zuclopenthixol—Headache—Hydrocortisone—rheumatoid arthritis	0.000409	0.00053	CcSEcCtD
Zuclopenthixol—Dizziness—Triamcinolone—rheumatoid arthritis	0.000406	0.000527	CcSEcCtD
Zuclopenthixol—Anaphylactic shock—Methotrexate—rheumatoid arthritis	0.000406	0.000526	CcSEcCtD
Zuclopenthixol—Dizziness—Methylprednisolone—rheumatoid arthritis	0.000405	0.000525	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Prednisone—rheumatoid arthritis	0.0004	0.000519	CcSEcCtD
Zuclopenthixol—Asthenia—Dexamethasone—rheumatoid arthritis	0.0004	0.000518	CcSEcCtD
Zuclopenthixol—Asthenia—Betamethasone—rheumatoid arthritis	0.0004	0.000518	CcSEcCtD
Zuclopenthixol—Nervous system disorder—Methotrexate—rheumatoid arthritis	0.000398	0.000516	CcSEcCtD
Zuclopenthixol—Thrombocytopenia—Methotrexate—rheumatoid arthritis	0.000397	0.000515	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Prednisone—rheumatoid arthritis	0.000397	0.000515	CcSEcCtD
Zuclopenthixol—Nausea—Prednisolone—rheumatoid arthritis	0.000397	0.000514	CcSEcCtD
Zuclopenthixol—Pruritus—Betamethasone—rheumatoid arthritis	0.000394	0.000511	CcSEcCtD
Zuclopenthixol—Pruritus—Dexamethasone—rheumatoid arthritis	0.000394	0.000511	CcSEcCtD
Zuclopenthixol—Skin disorder—Methotrexate—rheumatoid arthritis	0.000394	0.000511	CcSEcCtD
Zuclopenthixol—Hyperhidrosis—Methotrexate—rheumatoid arthritis	0.000392	0.000508	CcSEcCtD
Zuclopenthixol—Vomiting—Triamcinolone—rheumatoid arthritis	0.000391	0.000506	CcSEcCtD
Zuclopenthixol—Vomiting—Methylprednisolone—rheumatoid arthritis	0.00039	0.000505	CcSEcCtD
Zuclopenthixol—Nausea—Hydrocortisone—rheumatoid arthritis	0.000388	0.000502	CcSEcCtD
Zuclopenthixol—Rash—Triamcinolone—rheumatoid arthritis	0.000387	0.000502	CcSEcCtD
Zuclopenthixol—Dermatitis—Triamcinolone—rheumatoid arthritis	0.000387	0.000502	CcSEcCtD
Zuclopenthixol—Anorexia—Methotrexate—rheumatoid arthritis	0.000387	0.000501	CcSEcCtD
Zuclopenthixol—Rash—Methylprednisolone—rheumatoid arthritis	0.000387	0.000501	CcSEcCtD
Zuclopenthixol—Dermatitis—Methylprednisolone—rheumatoid arthritis	0.000386	0.0005	CcSEcCtD
Zuclopenthixol—Headache—Triamcinolone—rheumatoid arthritis	0.000385	0.000499	CcSEcCtD
Zuclopenthixol—Headache—Methylprednisolone—rheumatoid arthritis	0.000384	0.000498	CcSEcCtD
Zuclopenthixol—Body temperature increased—Prednisone—rheumatoid arthritis	0.000384	0.000497	CcSEcCtD
Zuclopenthixol—Abdominal pain—Prednisone—rheumatoid arthritis	0.000384	0.000497	CcSEcCtD
Zuclopenthixol—Diarrhoea—Dexamethasone—rheumatoid arthritis	0.000381	0.000494	CcSEcCtD
Zuclopenthixol—Diarrhoea—Betamethasone—rheumatoid arthritis	0.000381	0.000494	CcSEcCtD
Zuclopenthixol—Hypotension—Methotrexate—rheumatoid arthritis	0.000379	0.000491	CcSEcCtD
Zuclopenthixol—Musculoskeletal discomfort—Methotrexate—rheumatoid arthritis	0.00037	0.000479	CcSEcCtD
Zuclopenthixol—Dizziness—Betamethasone—rheumatoid arthritis	0.000369	0.000478	CcSEcCtD
Zuclopenthixol—Dizziness—Dexamethasone—rheumatoid arthritis	0.000369	0.000478	CcSEcCtD
Zuclopenthixol—Insomnia—Methotrexate—rheumatoid arthritis	0.000367	0.000476	CcSEcCtD
Zuclopenthixol—Nausea—Triamcinolone—rheumatoid arthritis	0.000365	0.000473	CcSEcCtD
Zuclopenthixol—Paraesthesia—Methotrexate—rheumatoid arthritis	0.000364	0.000472	CcSEcCtD
Zuclopenthixol—Nausea—Methylprednisolone—rheumatoid arthritis	0.000364	0.000472	CcSEcCtD
Zuclopenthixol—Dyspnoea—Methotrexate—rheumatoid arthritis	0.000362	0.000469	CcSEcCtD
Zuclopenthixol—Somnolence—Methotrexate—rheumatoid arthritis	0.000361	0.000467	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Prednisone—rheumatoid arthritis	0.000358	0.000464	CcSEcCtD
Zuclopenthixol—Dyspepsia—Methotrexate—rheumatoid arthritis	0.000357	0.000463	CcSEcCtD
Zuclopenthixol—Vomiting—Betamethasone—rheumatoid arthritis	0.000354	0.000459	CcSEcCtD
Zuclopenthixol—Vomiting—Dexamethasone—rheumatoid arthritis	0.000354	0.000459	CcSEcCtD
Zuclopenthixol—Decreased appetite—Methotrexate—rheumatoid arthritis	0.000353	0.000457	CcSEcCtD
Zuclopenthixol—Rash—Dexamethasone—rheumatoid arthritis	0.000352	0.000456	CcSEcCtD
Zuclopenthixol—Rash—Betamethasone—rheumatoid arthritis	0.000352	0.000456	CcSEcCtD
Zuclopenthixol—Dermatitis—Dexamethasone—rheumatoid arthritis	0.000351	0.000455	CcSEcCtD
Zuclopenthixol—Dermatitis—Betamethasone—rheumatoid arthritis	0.000351	0.000455	CcSEcCtD
Zuclopenthixol—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	0.00035	0.000454	CcSEcCtD
Zuclopenthixol—Fatigue—Methotrexate—rheumatoid arthritis	0.00035	0.000453	CcSEcCtD
Zuclopenthixol—Headache—Dexamethasone—rheumatoid arthritis	0.000349	0.000453	CcSEcCtD
Zuclopenthixol—Headache—Betamethasone—rheumatoid arthritis	0.000349	0.000453	CcSEcCtD
Zuclopenthixol—Asthenia—Prednisone—rheumatoid arthritis	0.000348	0.000451	CcSEcCtD
Zuclopenthixol—Pain—Methotrexate—rheumatoid arthritis	0.000347	0.00045	CcSEcCtD
Zuclopenthixol—Pruritus—Prednisone—rheumatoid arthritis	0.000343	0.000445	CcSEcCtD
Zuclopenthixol—Feeling abnormal—Methotrexate—rheumatoid arthritis	0.000334	0.000433	CcSEcCtD
Zuclopenthixol—Diarrhoea—Prednisone—rheumatoid arthritis	0.000332	0.000431	CcSEcCtD
Zuclopenthixol—Gastrointestinal pain—Methotrexate—rheumatoid arthritis	0.000332	0.00043	CcSEcCtD
Zuclopenthixol—Nausea—Betamethasone—rheumatoid arthritis	0.000331	0.000429	CcSEcCtD
Zuclopenthixol—Nausea—Dexamethasone—rheumatoid arthritis	0.000331	0.000429	CcSEcCtD
Zuclopenthixol—Dizziness—Prednisone—rheumatoid arthritis	0.000321	0.000416	CcSEcCtD
Zuclopenthixol—Abdominal pain—Methotrexate—rheumatoid arthritis	0.000321	0.000416	CcSEcCtD
Zuclopenthixol—Body temperature increased—Methotrexate—rheumatoid arthritis	0.000321	0.000416	CcSEcCtD
Zuclopenthixol—Vomiting—Prednisone—rheumatoid arthritis	0.000309	0.0004	CcSEcCtD
Zuclopenthixol—Rash—Prednisone—rheumatoid arthritis	0.000306	0.000397	CcSEcCtD
Zuclopenthixol—Dermatitis—Prednisone—rheumatoid arthritis	0.000306	0.000396	CcSEcCtD
Zuclopenthixol—Headache—Prednisone—rheumatoid arthritis	0.000304	0.000394	CcSEcCtD
Zuclopenthixol—Hypersensitivity—Methotrexate—rheumatoid arthritis	0.000299	0.000387	CcSEcCtD
Zuclopenthixol—Asthenia—Methotrexate—rheumatoid arthritis	0.000291	0.000377	CcSEcCtD
Zuclopenthixol—Nausea—Prednisone—rheumatoid arthritis	0.000288	0.000374	CcSEcCtD
Zuclopenthixol—Pruritus—Methotrexate—rheumatoid arthritis	0.000287	0.000372	CcSEcCtD
Zuclopenthixol—Diarrhoea—Methotrexate—rheumatoid arthritis	0.000278	0.00036	CcSEcCtD
Zuclopenthixol—Dizziness—Methotrexate—rheumatoid arthritis	0.000268	0.000348	CcSEcCtD
Zuclopenthixol—Vomiting—Methotrexate—rheumatoid arthritis	0.000258	0.000334	CcSEcCtD
Zuclopenthixol—Rash—Methotrexate—rheumatoid arthritis	0.000256	0.000332	CcSEcCtD
Zuclopenthixol—Dermatitis—Methotrexate—rheumatoid arthritis	0.000256	0.000331	CcSEcCtD
Zuclopenthixol—Headache—Methotrexate—rheumatoid arthritis	0.000254	0.000329	CcSEcCtD
Zuclopenthixol—Nausea—Methotrexate—rheumatoid arthritis	0.000241	0.000312	CcSEcCtD
Zuclopenthixol—ADRA2A—Hemostasis—VEGFA—rheumatoid arthritis	4.39e-05	0.000192	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—IL2—rheumatoid arthritis	4.39e-05	0.000192	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—IL6ST—rheumatoid arthritis	4.38e-05	0.000192	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—CCL2—rheumatoid arthritis	4.38e-05	0.000192	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—C3—rheumatoid arthritis	4.38e-05	0.000192	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—ADRBK1—rheumatoid arthritis	4.37e-05	0.000191	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—IL6R—rheumatoid arthritis	4.37e-05	0.000191	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CXCL10—rheumatoid arthritis	4.37e-05	0.000191	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—STAT1—rheumatoid arthritis	4.36e-05	0.000191	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—STAT1—rheumatoid arthritis	4.35e-05	0.00019	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—PRKCQ—rheumatoid arthritis	4.34e-05	0.00019	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—POMC—rheumatoid arthritis	4.32e-05	0.000189	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—CCL2—rheumatoid arthritis	4.31e-05	0.000189	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—CCL2—rheumatoid arthritis	4.3e-05	0.000188	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—IL6R—rheumatoid arthritis	4.3e-05	0.000188	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CXCL10—rheumatoid arthritis	4.3e-05	0.000188	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—IL6R—rheumatoid arthritis	4.29e-05	0.000188	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CXCL10—rheumatoid arthritis	4.29e-05	0.000188	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—CD80—rheumatoid arthritis	4.29e-05	0.000188	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—STAT1—rheumatoid arthritis	4.27e-05	0.000187	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—CAT—rheumatoid arthritis	4.24e-05	0.000186	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—CCL2—rheumatoid arthritis	4.22e-05	0.000185	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—IL6R—rheumatoid arthritis	4.21e-05	0.000184	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CXCL10—rheumatoid arthritis	4.21e-05	0.000184	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—RASGRP1—rheumatoid arthritis	4.12e-05	0.000181	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—SYK—rheumatoid arthritis	4.11e-05	0.00018	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—CXCL8—rheumatoid arthritis	4.08e-05	0.000179	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—LEP—rheumatoid arthritis	4.08e-05	0.000179	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—POMC—rheumatoid arthritis	4.07e-05	0.000178	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—PRKCQ—rheumatoid arthritis	4.04e-05	0.000177	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Hemostasis—TGFB1—rheumatoid arthritis	4.03e-05	0.000176	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—POMC—rheumatoid arthritis	4.01e-05	0.000176	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—CCL2—rheumatoid arthritis	3.98e-05	0.000174	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—MMP3—rheumatoid arthritis	3.98e-05	0.000174	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—TYK2—rheumatoid arthritis	3.98e-05	0.000174	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—IL6R—rheumatoid arthritis	3.97e-05	0.000174	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—STAT1—rheumatoid arthritis	3.96e-05	0.000174	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—CCL2—rheumatoid arthritis	3.92e-05	0.000172	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—MMP3—rheumatoid arthritis	3.92e-05	0.000172	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—TYK2—rheumatoid arthritis	3.92e-05	0.000171	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—IL6R—rheumatoid arthritis	3.91e-05	0.000171	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—MMP3—rheumatoid arthritis	3.91e-05	0.000171	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CXCL10—rheumatoid arthritis	3.91e-05	0.000171	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—TYK2—rheumatoid arthritis	3.91e-05	0.000171	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—IL2—rheumatoid arthritis	3.9e-05	0.000171	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling by GPCR—IL6—rheumatoid arthritis	3.88e-05	0.00017	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—FN1—rheumatoid arthritis	3.85e-05	0.000168	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—ENO1—rheumatoid arthritis	3.84e-05	0.000168	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—MMP3—rheumatoid arthritis	3.84e-05	0.000168	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—TYK2—rheumatoid arthritis	3.83e-05	0.000168	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—PTK2—rheumatoid arthritis	3.83e-05	0.000168	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—IL6ST—rheumatoid arthritis	3.83e-05	0.000168	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—CXCL8—rheumatoid arthritis	3.82e-05	0.000167	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—PTK2—rheumatoid arthritis	3.77e-05	0.000165	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—PTK2—rheumatoid arthritis	3.76e-05	0.000165	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CCL5—rheumatoid arthritis	3.76e-05	0.000165	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—CXCL8—rheumatoid arthritis	3.75e-05	0.000164	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—CXCL8—rheumatoid arthritis	3.75e-05	0.000164	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CSF2—rheumatoid arthritis	3.7e-05	0.000162	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CCL5—rheumatoid arthritis	3.7e-05	0.000162	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—PTK2—rheumatoid arthritis	3.69e-05	0.000162	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—MMP9—rheumatoid arthritis	3.69e-05	0.000162	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CCL5—rheumatoid arthritis	3.69e-05	0.000162	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—CD80—rheumatoid arthritis	3.69e-05	0.000161	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—CXCL8—rheumatoid arthritis	3.68e-05	0.000161	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—NFKB1—rheumatoid arthritis	3.65e-05	0.00016	CbGpPWpGaD
Zuclopenthixol—DRD2—GPCR downstream signaling—IL2—rheumatoid arthritis	3.65e-05	0.00016	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CSF2—rheumatoid arthritis	3.64e-05	0.000159	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CSF2—rheumatoid arthritis	3.63e-05	0.000159	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CCL5—rheumatoid arthritis	3.62e-05	0.000159	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—TYK2—rheumatoid arthritis	3.62e-05	0.000158	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—MAPK8—rheumatoid arthritis	3.59e-05	0.000157	CbGpPWpGaD
Zuclopenthixol—HTR2A—GPCR downstream signaling—IL2—rheumatoid arthritis	3.59e-05	0.000157	CbGpPWpGaD
Zuclopenthixol—HRH1—GPCR downstream signaling—IL2—rheumatoid arthritis	3.58e-05	0.000157	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CSF2—rheumatoid arthritis	3.57e-05	0.000156	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—MMP3—rheumatoid arthritis	3.56e-05	0.000156	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—TYK2—rheumatoid arthritis	3.56e-05	0.000156	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—NOS3—rheumatoid arthritis	3.55e-05	0.000155	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—MTHFR—rheumatoid arthritis	3.54e-05	0.000155	CbGpPWpGaD
Zuclopenthixol—ADRA1A—GPCR downstream signaling—IL2—rheumatoid arthritis	3.51e-05	0.000154	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—POMC—rheumatoid arthritis	3.5e-05	0.000153	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—SPP1—rheumatoid arthritis	3.48e-05	0.000152	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—CXCL8—rheumatoid arthritis	3.47e-05	0.000152	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—PTK2—rheumatoid arthritis	3.43e-05	0.00015	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—CCL2—rheumatoid arthritis	3.43e-05	0.00015	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—SPP1—rheumatoid arthritis	3.42e-05	0.00015	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—IL6R—rheumatoid arthritis	3.42e-05	0.00015	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—SPP1—rheumatoid arthritis	3.42e-05	0.00015	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—CXCL8—rheumatoid arthritis	3.42e-05	0.00015	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—CXCL8—rheumatoid arthritis	3.41e-05	0.000149	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—CXCL8—rheumatoid arthritis	3.4e-05	0.000149	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CCR5—rheumatoid arthritis	3.39e-05	0.000148	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CCL5—rheumatoid arthritis	3.36e-05	0.000147	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—SPP1—rheumatoid arthritis	3.35e-05	0.000147	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—CXCL8—rheumatoid arthritis	3.34e-05	0.000146	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—IL2RA—rheumatoid arthritis	3.34e-05	0.000146	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CCR5—rheumatoid arthritis	3.33e-05	0.000146	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CCR5—rheumatoid arthritis	3.32e-05	0.000146	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Hemostasis—TP53—rheumatoid arthritis	3.32e-05	0.000145	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—VEGFA—rheumatoid arthritis	3.31e-05	0.000145	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CSF2—rheumatoid arthritis	3.31e-05	0.000145	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—IL2—rheumatoid arthritis	3.31e-05	0.000145	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—C3—rheumatoid arthritis	3.31e-05	0.000145	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—IL2RA—rheumatoid arthritis	3.28e-05	0.000144	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—IL2RA—rheumatoid arthritis	3.28e-05	0.000143	CbGpPWpGaD
Zuclopenthixol—ADRA2A—GPCR downstream signaling—IL2—rheumatoid arthritis	3.26e-05	0.000143	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CCR5—rheumatoid arthritis	3.26e-05	0.000143	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—IL2—rheumatoid arthritis	3.26e-05	0.000143	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—C3—rheumatoid arthritis	3.26e-05	0.000143	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—IL2—rheumatoid arthritis	3.25e-05	0.000142	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—C3—rheumatoid arthritis	3.25e-05	0.000142	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—IL2RA—rheumatoid arthritis	3.22e-05	0.000141	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—IL2—rheumatoid arthritis	3.19e-05	0.00014	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—C3—rheumatoid arthritis	3.19e-05	0.00014	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—CXCL8—rheumatoid arthritis	3.15e-05	0.000138	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—SPP1—rheumatoid arthritis	3.12e-05	0.000136	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—TYK2—rheumatoid arthritis	3.11e-05	0.000136	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—CXCL8—rheumatoid arthritis	3.1e-05	0.000136	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—LEP—rheumatoid arthritis	3.08e-05	0.000135	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—NOS3—rheumatoid arthritis	3.06e-05	0.000134	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—TGFB1—rheumatoid arthritis	3.04e-05	0.000133	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—LEP—rheumatoid arthritis	3.03e-05	0.000133	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CCR5—rheumatoid arthritis	3.03e-05	0.000133	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—LEP—rheumatoid arthritis	3.02e-05	0.000132	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—IL2—rheumatoid arthritis	3.01e-05	0.000132	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling by GPCR—IL6—rheumatoid arthritis	3e-05	0.000131	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—IL2RA—rheumatoid arthritis	2.99e-05	0.000131	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—LEP—rheumatoid arthritis	2.97e-05	0.00013	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—IL2—rheumatoid arthritis	2.96e-05	0.00013	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—C3—rheumatoid arthritis	2.96e-05	0.00013	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—FN1—rheumatoid arthritis	2.9e-05	0.000127	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—IL6ST—rheumatoid arthritis	2.89e-05	0.000127	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—FN1—rheumatoid arthritis	2.86e-05	0.000125	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—FN1—rheumatoid arthritis	2.85e-05	0.000125	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—MMP9—rheumatoid arthritis	2.85e-05	0.000125	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—IL6ST—rheumatoid arthritis	2.85e-05	0.000125	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—IL6ST—rheumatoid arthritis	2.84e-05	0.000124	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—POMC—rheumatoid arthritis	2.83e-05	0.000124	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—NFKB1—rheumatoid arthritis	2.82e-05	0.000123	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—FN1—rheumatoid arthritis	2.8e-05	0.000123	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—IL6ST—rheumatoid arthritis	2.79e-05	0.000122	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CD80—rheumatoid arthritis	2.79e-05	0.000122	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—MAPK8—rheumatoid arthritis	2.77e-05	0.000121	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—CAT—rheumatoid arthritis	2.77e-05	0.000121	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—LEP—rheumatoid arthritis	2.76e-05	0.000121	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CD80—rheumatoid arthritis	2.74e-05	0.00012	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CD80—rheumatoid arthritis	2.73e-05	0.00012	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—CXCL8—rheumatoid arthritis	2.71e-05	0.000119	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CD80—rheumatoid arthritis	2.68e-05	0.000117	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—POMC—rheumatoid arthritis	2.65e-05	0.000116	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—POMC—rheumatoid arthritis	2.6e-05	0.000114	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—FN1—rheumatoid arthritis	2.6e-05	0.000114	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—POMC—rheumatoid arthritis	2.6e-05	0.000114	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—IL2—rheumatoid arthritis	2.59e-05	0.000113	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—IL6ST—rheumatoid arthritis	2.59e-05	0.000113	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CCL2—rheumatoid arthritis	2.59e-05	0.000113	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—ALB—rheumatoid arthritis	2.58e-05	0.000113	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—IL6R—rheumatoid arthritis	2.58e-05	0.000113	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling by GPCR—IL6—rheumatoid arthritis	2.58e-05	0.000113	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—VEGFA—rheumatoid arthritis	2.56e-05	0.000112	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—POMC—rheumatoid arthritis	2.55e-05	0.000112	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CCL2—rheumatoid arthritis	2.55e-05	0.000112	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CCL2—rheumatoid arthritis	2.54e-05	0.000111	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—IL6R—rheumatoid arthritis	2.54e-05	0.000111	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—IL6R—rheumatoid arthritis	2.53e-05	0.000111	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—TP53—rheumatoid arthritis	2.5e-05	0.00011	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CCL2—rheumatoid arthritis	2.49e-05	0.000109	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CD80—rheumatoid arthritis	2.49e-05	0.000109	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—IL6R—rheumatoid arthritis	2.49e-05	0.000109	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—NOS3—rheumatoid arthritis	2.47e-05	0.000108	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—MMP9—rheumatoid arthritis	2.45e-05	0.000107	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—NFKB1—rheumatoid arthritis	2.43e-05	0.000106	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—MAPK8—rheumatoid arthritis	2.39e-05	0.000104	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—POMC—rheumatoid arthritis	2.37e-05	0.000104	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—TYK2—rheumatoid arthritis	2.35e-05	0.000103	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—TGFB1—rheumatoid arthritis	2.35e-05	0.000103	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CCL2—rheumatoid arthritis	2.32e-05	0.000101	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—TYK2—rheumatoid arthritis	2.31e-05	0.000101	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—IL6R—rheumatoid arthritis	2.31e-05	0.000101	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—TYK2—rheumatoid arthritis	2.31e-05	0.000101	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—MTHFR—rheumatoid arthritis	2.31e-05	0.000101	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—NOS3—rheumatoid arthritis	2.31e-05	0.000101	CbGpPWpGaD
Zuclopenthixol—DRD5—Signaling Pathways—IL6—rheumatoid arthritis	2.29e-05	0.0001	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—NOS3—rheumatoid arthritis	2.27e-05	9.94e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—NOS3—rheumatoid arthritis	2.27e-05	9.92e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—TYK2—rheumatoid arthritis	2.27e-05	9.92e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Metabolism—PTGS2—rheumatoid arthritis	2.26e-05	9.89e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—NOS3—rheumatoid arthritis	2.22e-05	9.73e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—VEGFA—rheumatoid arthritis	2.2e-05	9.64e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—TYK2—rheumatoid arthritis	2.1e-05	9.21e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—NOS3—rheumatoid arthritis	2.07e-05	9.04e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—CXCL8—rheumatoid arthritis	2.05e-05	8.96e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—TGFB1—rheumatoid arthritis	2.02e-05	8.85e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—CXCL8—rheumatoid arthritis	2.01e-05	8.82e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—CXCL8—rheumatoid arthritis	2.01e-05	8.8e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—CXCL8—rheumatoid arthritis	1.97e-05	8.63e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—IL2—rheumatoid arthritis	1.96e-05	8.56e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling by GPCR—IL6—rheumatoid arthritis	1.95e-05	8.52e-05	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—TP53—rheumatoid arthritis	1.93e-05	8.46e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—IL2—rheumatoid arthritis	1.92e-05	8.43e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—IL2—rheumatoid arthritis	1.92e-05	8.41e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling by GPCR—IL6—rheumatoid arthritis	1.92e-05	8.39e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling by GPCR—IL6—rheumatoid arthritis	1.91e-05	8.37e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—IL2—rheumatoid arthritis	1.88e-05	8.25e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling by GPCR—IL6—rheumatoid arthritis	1.88e-05	8.21e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—MMP9—rheumatoid arthritis	1.85e-05	8.11e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—POMC—rheumatoid arthritis	1.85e-05	8.08e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—CXCL8—rheumatoid arthritis	1.83e-05	8.02e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—NFKB1—rheumatoid arthritis	1.83e-05	8.02e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—MMP9—rheumatoid arthritis	1.82e-05	7.98e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—MMP9—rheumatoid arthritis	1.82e-05	7.96e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—NFKB1—rheumatoid arthritis	1.8e-05	7.89e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—MAPK8—rheumatoid arthritis	1.8e-05	7.88e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—NFKB1—rheumatoid arthritis	1.8e-05	7.87e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—MMP9—rheumatoid arthritis	1.78e-05	7.81e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—MAPK8—rheumatoid arthritis	1.77e-05	7.76e-05	CbGpPWpGaD
Zuclopenthixol—HTR6—Signaling Pathways—IL6—rheumatoid arthritis	1.77e-05	7.75e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—MAPK8—rheumatoid arthritis	1.77e-05	7.74e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—NFKB1—rheumatoid arthritis	1.76e-05	7.73e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—IL2—rheumatoid arthritis	1.75e-05	7.67e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling by GPCR—IL6—rheumatoid arthritis	1.74e-05	7.63e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—MAPK8—rheumatoid arthritis	1.73e-05	7.6e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—ALB—rheumatoid arthritis	1.68e-05	7.37e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—TP53—rheumatoid arthritis	1.66e-05	7.28e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—VEGFA—rheumatoid arthritis	1.66e-05	7.28e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—MMP9—rheumatoid arthritis	1.66e-05	7.26e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—NFKB1—rheumatoid arthritis	1.64e-05	7.18e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—VEGFA—rheumatoid arthritis	1.64e-05	7.16e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—VEGFA—rheumatoid arthritis	1.63e-05	7.15e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—MAPK8—rheumatoid arthritis	1.61e-05	7.06e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—NOS3—rheumatoid arthritis	1.61e-05	7.05e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—VEGFA—rheumatoid arthritis	1.6e-05	7.01e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—TGFB1—rheumatoid arthritis	1.53e-05	6.68e-05	CbGpPWpGaD
Zuclopenthixol—DRD1—Signaling Pathways—IL6—rheumatoid arthritis	1.52e-05	6.67e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—TGFB1—rheumatoid arthritis	1.5e-05	6.57e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—TGFB1—rheumatoid arthritis	1.5e-05	6.56e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—VEGFA—rheumatoid arthritis	1.49e-05	6.52e-05	CbGpPWpGaD
Zuclopenthixol—CYP2D6—Metabolism—PTGS2—rheumatoid arthritis	1.47e-05	6.45e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—TGFB1—rheumatoid arthritis	1.47e-05	6.44e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—TGFB1—rheumatoid arthritis	1.37e-05	5.98e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—TP53—rheumatoid arthritis	1.26e-05	5.5e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—TP53—rheumatoid arthritis	1.24e-05	5.41e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—TP53—rheumatoid arthritis	1.23e-05	5.4e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—TP53—rheumatoid arthritis	1.21e-05	5.3e-05	CbGpPWpGaD
Zuclopenthixol—DRD2—Signaling Pathways—IL6—rheumatoid arthritis	1.15e-05	5.03e-05	CbGpPWpGaD
Zuclopenthixol—HTR2A—Signaling Pathways—IL6—rheumatoid arthritis	1.13e-05	4.95e-05	CbGpPWpGaD
Zuclopenthixol—HRH1—Signaling Pathways—IL6—rheumatoid arthritis	1.13e-05	4.94e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—TP53—rheumatoid arthritis	1.12e-05	4.92e-05	CbGpPWpGaD
Zuclopenthixol—ADRA1A—Signaling Pathways—IL6—rheumatoid arthritis	1.11e-05	4.85e-05	CbGpPWpGaD
Zuclopenthixol—ADRA2A—Signaling Pathways—IL6—rheumatoid arthritis	1.03e-05	4.51e-05	CbGpPWpGaD
